Short-course targeted radiation for early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests a radiation plan called GammaPod to treat early breast cancer with precise targeting. It may help patients by delivering the treatment in a more focused way, while checking safety and tumor control in the smallest, well-defined cancers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a study consent form and be able to finish the study
- Your cancer must be invasive ductal breast cancer (not invasive lobular)
- You must be female and over age 45
- Your tumor must be one single spot (not multiple areas), under 3 cm
- Your cancer must be estrogen-receptor positive and HER2-negative
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a very short, high-dose radiation treatment given directly to the breast after lumpectomy. It aims to make radiation more convenient by finishing in just a few days instead of weeks, possibly with fewer side effects.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
This trial tests a new way to combine radiation therapy with ultrasound and tiny bubbles to treat breast cancer that has spread to the chest wall or is advanced. It aims to make radiation more effective and safer.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial tests a shorter, more intense course of radiation to the whole breast after chemotherapy in women age 60 or older with early-stage breast cancer. It is designed for those who had a lumpectomy and are at higher risk based on genetic tests like Mammaprint or Oncotype.
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.